lindane
Trade name: kwell
Approved
Jun 1, 1951
Lindane is an isomer of hexachlorocyclohexane that has been used both as an agricultural insecticide and as a pharmaceutical. As a shampoo, lindane is used for treamtment lice infestation. Lindane lotion is used for treatment of scabies. Due to toxicities, associated with lindane, it is used only in patients who cannot tolerate or have failed first-line treatment with safer medication. Lindane exerts its parasiticidal action by being directly absorbed into the parasites and their ova, where it interferes with GABA neurotransmitter function by interacting with the GABAA channel complex at the picrotoxin binding site. — NCATS
Clinical trial activity
2 trials · 2 clinical orgs · 6 marketing orgs
Earliest trial started May 1, 2009 (NCT02213055)
Timeline
1940s
- Jun 1, 1948
Block Drug — First NDA Organization
- Jun 1, 1948
Block Drug — NDA Organization
1950s
- Jun 1, 1951
Earliest FDA Approval
1970s
- Dec 19, 1974
Carnrick Laboratories — Marketing Organization
- Jun 15, 1976
Johnson and Johnson — Marketing Organization
1980s
- Dec 17, 1981
Olta Pharms — Marketing Organization
- Sep 18, 1984
Wockhardt — Marketing Organization
2000s
- Jan 1, 2009
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- GABA-A receptorNEGATIVE ALLOSTERIC MODULATOR
GABA-A receptor negative allosteric modulator
mode not clear, but seems negative and likely allosteric, binds at picrotoxin site?
- GABA-A receptorNEGATIVE ALLOSTERIC MODULATOR
GABA-A receptor negative allosteric modulator
mode not clear, but seems negative and likely allosteric, binds at picrotoxin site?
Approval history
- approvedJun 1, 1951
Chemistry & pharmacology
SMILES
Cl[C@H]1[C@H](Cl)[C@H](Cl)[C@@H](Cl)[C@H](Cl)[C@@H]1Cl- Mol. weight
- 290.83 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Racemic Mixture
- Inorganic
- No
- Polymer
- No
- Delivery
- Topical
- Availability
- Prescription Only
Oral
No
Parenteral
No
Topical
Yes
Sources
- WikipediaLindane ↗
- NCATS59NEE7PCAB ↗
- ChEMBLCHEMBL3138621 ↗
- ChEMBLCHEMBL15891 ↗
- ChEMBLCHEMBL1201625 ↗
- ChEMBLCHEMBL1200468 ↗
Also known as
- 1,2,3,4,5,6-hexachlorocyclohexane
- 1,2,3,4,5,6-hexachlorocyclohexane
- (1alpha,2alpha,3beta,4alpha,5alpha,6beta)-1,2,3,4,5,6-hexachlorocyclohexane
- (1alpha,2alpha,3beta,4alpha,5alpha,6beta)-1,2,3,4,5,6-hexachlorocyclohexane
- (1r,2c,3t,4c,5c,6t)-1,2,3,4,5,6-hexachlorocyclohexane
- (1r,2c,3t,4c,5c,6t)-1,2,3,4,5,6-hexachlorocyclohexane
- benzene hexachloride
- benzene hexachloride
- benzene hexachloride, gamma
- benzene hexachloride, gamma
- esoderm
- esoderm
- gamene
- gamene
- gamma-1,2,3,4,5,6-hexachlorocyclohexane
- gamma-1,2,3,4,5,6-hexachlorocyclohexane
- gamma benzene hcl
- gamma benzene hexachloride
- gamma benzene hexachloride
- gamma-benzene hexachloride
- gamma-benzene hexachloride
- gamma-bhc
- gamma-bhc
- gamma-hch
- gamma-hch
- gamma-hexachlorocyclohexane
- gamma-hexachlorocyclohexane
- gamma-hexachlorocyclohexane
- gamma-hexachlorzyklohexan
- gamma-hexachlorzyklohexan
- gamma-lindane
- gamma-lindane
- gammallin
- gammallin
- gammallin
- gammaxene
- gammaxene
- gammaxene
- gammexane
- gammexane
- gexane
- gexane
- hexachloran
- hexachlorane
- hexachlorane
- hexachlorane
- hexachlorocyclohexane
- hexicide
- hexicide
- kwell
- kwell
- kwell
- kwells
- kwells
- kwells kids
- lindan
- lindan
- lindane
- lindane
- lindane
- lindane
- lindane
- lindane
- lindane
- lindane
- lindane
- lindane
- lindane
- lindane
- lorexane
- lorexane
- lorexane no 3
- quellada
- quellada
- quellada-m
- scabene
- scabene
- γ-hexachlorocyclohexane
- γ-hexachlorocyclohexane
- γ-hexachlorzyklohexan
- γ-hexachlorzyklohexan
- γ-lindane
- γ-lindane
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03270839 | Phase 4 | Jun 1, 2017 | Israel Defense Force |
| NCT02213055 | Phase 2 | May 1, 2009 | Rutgers University |
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Israel Defense Force | Government | 1 | 1 | 1 | 2017 |
| Rutgers University | Academic/Hospital | 1 | 1 | 1 | 2009 |
Marketing (8)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Block Drug | For profit | NDA | Jun 1, 1948 |
| Carnrick Laboratories | For profit | MKTG | Dec 19, 1974 |
| Carnrick Laboratories | For profit | NDA2 | — |
| Johnson and Johnson | For profit | MKTG | Jun 15, 1976 |
| Olta Pharms | For profit | MKTG | Dec 17, 1981 |
| Stiefel Laboratories | For profit | MKTG | — |
| Wockhardt | For profit | SYN | Aug 16, 1984 |
| Wockhardt | For profit | MKTG | Sep 18, 1984 |